J&J | JNJ - SCHULD





SCHULD Veränderung Datum
AbbVie USD 67.5B 67.5B 2025-12
Abbott USD 13.86B 919M 2025-12
Amgen USD 54.6B 17M 2025-12
AstraZeneca USD 33.92B 4.3B 2026-03
Baxter International USD 9.78B 68M 2025-12
Bayer EUR 36.45B 2.93B 2025-12
Becton, Dickinson and Co. USD 19.54B 358M 2025-12
Biogen USD 6.56B 275.1M 2026-03
Boston Scientific USD 11.44B 610M 2025-12
Bristol-Myers Squibb USD 47.14B 3.9B 2025-12
CONMED USD 834.94M 18.81M 2025-12
Cooper Companies USD 2.51B 27M 2025-09
Dexcom USD 1.24B 900K 2026-03
Edwards Lifesciences USD 600M 105.4M 2026-03
Eli Lilly USD 42.5B 3.6M 2025-12
Gilead Sciences USD 24.94B 5M 2025-12
GlaxoSmithKline GBP 19.06B 1.34B 2026-03
Globus Medical USD 118.66M 687K 2025-12
Insulet USD 949.2M 65.6M 2025-12
Integra LifeSciences USD 2.04B 6.27M 2026-03
Intuitive Surgical USD 0 0 2025-03
J&J USD 47.93B 2.14B 2025-12
Medtronic USD 28.07B 1.03B 2025-12
Merck USD 49.34B 7.97B 2025-12
Merit Medical Systems USD 821.57M 420K 2025-12
Novartis USD 47B 11.62B 2026-03
Pfizer USD 63.73B 231M 2026-03
Regeneron Pharmaceuticals USD 2.71B 300K 2026-03
Roche Holding CHF 33.03B 1.41B 2025-06
Sanofi EUR 20.33B 1.43B 2025-12
Stryker USD 14.22B 635M 2026-03
Tandem Diabetes Care USD 444.48M 4.81M 2025-12
Teva Pharmaceutical Industries USD 17.09B 21M 2025-12
Vertex Pharmaceuticals USD 1.99B 44M 2026-03
Zimmer Biomet Holdings USD 7.47B 48.1M 2026-03
Zoetis USD 9.24B 1.96B 2025-12